KMT2A and leukemia: For example, dormant AML cells engrafted in osteoblast-enriched regions were found to be resistant to cytarabine.185 MLL-AF9 murine leukemia-initiating cells localized to endosteal regions with higher ATP levels to promote cell self-renewal186 (Fig. 5.7).